Epilepsy in Pregnancy/Aneurysms Laura A. Kalayjian, M.D. and Cargill H. Alleyne, Jr., M.D. Prevent congenital malformations and poor cognitive outcomes in fetuses exposed to antiepilepsy drugs.Counsel women with epilepsy on decisions about breastfeeding and postpartum care.Diagnose subarachnoid hemorrhage (SAH).Reduce vasospasms and other serious complications in patients recovering from hemorrhages.Assess hemorrhage risks in patients with unruptured aneurysms. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Neurologic Issues Tiffany Chow, M.D. and Donna S. Lundy, Ph.D.Detect early signs of dementia in patients presenting with cognitive impairment.Describe measures that may delay or prevent the occurrence of dementia.Provide appropriate medical and psychosocial management of patients with early dementia.Assess and identify patients with neurologic voice disorders.Categorize dysarthria into several distinct types, as described in the Mayo Clinic classification. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
TIA/Stroke Andrew Stemer, M.D.,Steven C. Cramer, M.D. and Gilda M. Tafreshi, M.D. Determine whether patients experienced a TIA.Prevent patients with a history of TIAs from developing strokes.Recommend agents and treatments shown to improve outcomes after stroke. Describe recent and forthcoming advances related to restoring and repairing brain function after stroke.Identify etiologies often responsible for strokes in younger adults. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Parkinson Disease/Office Instruments Susan M. Maixner, M.D. and Roger L. Albin, M.D. Recognize neuropsychiatric symptoms in PD patients and identify possible coexisting depression.Prescribe appropriate treatment of depression in PD patients.Recognize and treat psychosis in PD patients.Identify risk factors for development of psychosis in PD.Screen for and diagnose cognitive impairment in the office using specialized scales and instruments. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Multiple Sclerosis Alexander Rae Grant, M.D. and Jeffrey Cohen, M.D.Recognize clinical, neurologic, and ophthalmologic symptoms associated with the onset of MS.Confirm a diagnosis of MS using up-to-date standards and protocols.Discuss approved first and second-line treatments for MS.Compare forthcoming oral therapies for MS.Address potential safety issues with soon-to-be-released agents for the treatment of MS. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Neurological Emergencies/Antithrombotic Agents Sarah J. Hon, D.O. and Clinton Wright, M.D. Review the differential diagnosis of coma in patients with negative computed tomography (CT) of the head.Recognize and treat status epilepticus.Assess patients presenting with fever and confusion. Utilize anticoagulant therapy in patients with nonvalvular atrial fibrillation.Discuss the use of antiplatelet agents in patients with early ischemic stroke and for secondary stroke prevention. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medication Overuse Headache:Part I Jennifer S. Kriegler, M.D. Identify medications and comorbid conditions associated with the development of MOH.Describe shared mechanisms and etiologies of headaches and other pain disorders.Restore headaches to episodic patterns by weaning key medications.Provide adjunctive treatments to help patients wean from medications associated with MOH.Prevent dangerous symptoms associated with medication toxicity and withdrawal.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medication Overuse Headache:Part 2 Michael Liebenstein, Ph.D.,Deborah E. Tepper, M.D. and Stewart J. Tepper, M.D. Identify psychiatric comorbidities in patients with MOH.Apply cognitive behavioral therapy and other behavioral interventions for treatment of MOH.Classify MOH and explain its physiologic basis.Describe the structural and functional changes that occur in the brain as the result of frequent migraine attacks and MOH.Discuss the role of long-term opioid use in the progression to chronic daily headache and opioid-induced hyperalgesia. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Stroke After TIA/Wellness and MS Mai N. Nguyen Huynh, M.D. and Mary Rensel, M.D. Identify patients at high risk for stroke following TIA. Conduct the urgent testing required after TIA.Compare results obtained when patients who have had a TIA are treated in a special TIA clinic 3 days after referral to results of treatment within 24 hr of referral.Utilize strategies that take into account the importance of nutrition, exercise, and comorbidities in patients with MS. Recognize the value of empowerment and self-efficacy in patients with MS. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Stents and Stroke Prevention/Neurorehabilitation Michael J. Alexander, M.D. and Carolee Winstein, Ph.D. List the indications and contraindications for carotid artery stenting. Compare the risks and benefits of carotid endarterectomy to those of carotid artery stenting. Utilize medical therapy and specialized stents for treatment of intracranial atherosclerotic disease. Design protocols capable of accurately measuring the effects of complex rehabilitative interventions in stroke patients. Assess clinical trials in the field of rehabilitation after stroke. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Possible Additional Course Available
If you have taken the current course listed here or if you need additional Neurology credits, please call 800-446-5599 and ask about new courses in stock that are not listed on the website.
Here's what our clients are saying about American Seminar Institute's CME seminars...
"ASI provided me with an ideal system to obtain important updates and CME credits in an ideal environment." William, MD, Boston, MA
"(I completed my) Neurology Review Course for 20 CMEs in Costa Rica, what a perfect location for earning CE! Program was seamless!" Margaret, MD, Dayton, OH
" I enjoyed this mode of learning-I find that with a family and work schedule, learning in in this way, with your program, works very well." Elizabeth, MD, Billings, MT
